Grants Search Results

This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: Consortium for Childhood Cancer Predisposition. For a description of this project, see the consortium grant made to the lead institution: Emory University, Atlanta, GA.

The North American Consortium for Histiocytosis, or NACHO, is a consortium dedicated to clinical and translational studies and biological research for histiocytic disorders. Histiocytic disorders are a group of diseases that occur when there is an over-production of white blood cells known as histiocytes that can lead to organ damage and tumor formation. This group is made up of a wide variety of conditions that can affect both children and adults. NACHO is operated through a partnership between St. Jude Children's Research Hospital and Texas Children's Hospital. NACHO was created in 2014 in order to meet the need for a coordinated effort to combat histiocytic disorders. Histiocytic disorders have not previously been a priority for large, multi-site research cooperative groups, which has left these disorders with a lack of progress towards increased knowledge and new therapies. NACHO aims to bring together various hospitals and research institutions to collaborate and share experiences in order to further the advancement of histiocytic disorders. NACHO currently has 49 member institutions across the United States and Canada and aims to keep expanding so that children all over North America will have access to clinical trials that could save their lives. Funds administered by St. Jude Children's Research Hospital.

Move for Miles Childhood Cancer Foundation is generously supporting this research because they know research is how to drive change and improve the future. The foundation's inspiration comes from Miles himself who was diagnosed with Langerhans Cell Histiocytosis. Even through his fight, he has a joy and love for life and being outdoors. His family calls him sMiles because even though he has faced many obstacles, he still keeps smiling and moving.

This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.

Childhood cancer remains the leading cause of illness-related death in children. We now know that inherited genetic abnormalities contribute to cause cancer in many more children than previously understood. Children with Cancer Predisposition Syndromes (CPS) have a high risk of cancer, and we have a unique opportunity to prevent or detect cancer at early stages to improve their survival, as well as to better understand mechanisms of cancer development for all pediatric tumors. However, these CPS are rare and difficult to study in individual institutions. Thus, the creation of the Consortium for Childhood Cancer Predisposition, through which we will study surveillance and prevention strategies efficiently, by utilizing coordinated efforts to collect data and samples from patients with a CPS (creating a registry and biorepository). The Consortium will initially be composed of seven institutions and led by individuals who have already worked together to have significant impacts in this field, and will engage syndrome-specific advocacy groups to accelerate patient-centered advances. We expect that the impact of this Consortium will be improved outcomes for those at the highest risk of cancer through better identification, early tumor detection, optimized psychosocial support and cancer prevention. Funds administered by Emory University.

This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: Consortium for Childhood Cancer Predisposition. For a description of this project, see the consortium grant made to the lead institution: Emory University, Atlanta, GA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: Consortium for Childhood Cancer Predisposition. For a description of this project, see the consortium grant made to the lead institution: Emory University, Atlanta, GA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.